Home > Income Statement > ALEMBIC

ALEMBIC
Revenue

    Back to Income Statement
ALEMBIC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ALEMBIC
Please provide your vote to see the results

ALEMBIC Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹157 Cr₹127 Cr₹78 Cr₹74 Cr₹74 Cr

What is the latest Revenue of ALEMBIC ?

The latest Revenue ratio of ALEMBIC is ₹157 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹157 Cr
Mar2023₹127 Cr
Mar2022₹78 Cr
Mar2021₹74 Cr
Mar2020₹74 Cr

How is Revenue of ALEMBIC Trending?

Years Revenue % Change
Mar2024 ₹157 Cr
23.77
Mar2023 ₹127 Cr
62.68
Mar2022 ₹78 Cr
6.40
Mar2021 ₹74 Cr
-0.55
Mar2020 ₹74 Cr -

Compare Revenue of peers of ALEMBIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC ₹2,512.8 Cr -1.2% -9% 8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -3.4% -0.2% 18.1% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.3% 3.4% 55.5% Stock Analytics
CIPLA ₹119,410.0 Cr -2.6% -0.6% 5.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -2.3% -2.1% 20.4% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -2.9% -0.2% -8.7% Stock Analytics


ALEMBIC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC

-1.2%

-9%

8%

SENSEX

0.1%

4.9%

7.7%


You may also like the below Video Courses